This initiative by the four major European countries follows in the footsteps of several smaller countries – pointing to a new level of confidence in cheap vaccine that appears to be the best prospect of accelerating the COVID-19 vaccine across developing countries.
Experts point out that there is no clear evidence that the vaccine causes the disease, and cases are being investigated by regulators. But recent worries are already following questions from scientists how the company merged with a security and strength of his vaccine. Coming soon AstraZeneca is expected to release results from major medical tests that will determine whether the FDA approves the vaccine for use in the US.
Vaccination in Europe was sparked by reports of three cases, including one patient dying, among people who had been vaccinated in Norway, and another death in Denmark. Mu words released on March 11, the European Medicines Agency – an EU-based regulator similar to the FDA – said there had been 30 cases of “thromboembolic events,” or blood clots, among the 5 million people who received AstraZeneca shots in the EU.
“So far there is no evidence that the vaccine has brought about these conditions, which have not been identified as a side effect of the vaccine,” the EMA said. “The role of the EMA komiti is to ensure that the benefits of the vaccine outweigh the risks and that they can continue to provide the vaccine.”
AstraZeneca said there have been 37 cases of lung and vascular injury, caused by blood transfusions, which are relatively low compared to the general population.
“Approximately 17 million people in the EU and UK have now received our vaccine, and the amount of blood frozen in this group is lower than expected in cases,” said Ann Taylor. a words was released on March 14th.
And this is the World Health Organization urging countries to continue using the vaccine, insisting that there is no evidence that it causes bleeding. WHO experts are meeting to discuss blood-related reports Tuesday.
However, only a handful of events are making some countries stand out. According to German Health Minister Jens Spahn, there have been seven well-known cases, Diseases of venous sinus thrombosis (CVST), out of 1.6 million people were vaccinated against AstraZeneca in Germany. The Paul Ehrlich Institute, which is part of the German Ministry of Health, said Monday that concerned that the disease was reported in conjunction with an abnormal blood flow and high blood pressure, which makes the blood clot and stops bleeding.
The few cases that have appeared in Germany so far would have been more than they expected, but they could be few. “[T]The increase in the number of such cases is significant even if there is no reason to do so, ” said Paul Hunter, a health professional at the University of East Anglia, in a comment released through the UK Media Media Center.
The EMA is meeting to discuss concerns over blood transfusions on Tuesday and is expected to release the findings on Thursday. Prolonged vaccination could be a matter of concern, as cases of COVID-19 are also on the rise in several EU countries – with Italy facing especially dangerous – as several types of transmission spread.
Experts linked to BuzzFeed News said that, with little knowledge of the patients’ cases, there was not enough evidence to establish whether the vaccine had caused a blood clot. “We want to know the age of the cases, the medical history, and the risk factors for blood transfusions,” says Orly Vardeny of the University of Minnesota, a specialist in cardiology.
“It may or may not be vaccinated. If it is vaccinated, and if it does not appear anywhere, its explanation could be a commercial one, “John Moore, a virologist at Weill Cornell Medical College in New York who works on vaccine development, told BuzzFeed News. including Austria, stay stopped vaccination from other AstraZeneca vaccine groups.)
These new problems are more recent when the AVZececec’s COVID-19 vaccine was discontinued, developed at Oxford University. Back in November, AstraZeneca claimed in Press release that his vaccine was 70% complete effective, and could be up to 90% if given in half the first dose at the first shot. But many scientists he was skeptical, especially after the company that sold the drug admitted that the control was due to a incorrect distortion. AstraZeneca later added to the confusion with change its definition due to 90% success from individual tests to remaining between the two drugs.
The biggest pain came in February, when tests in South Africa showed the vaccine it was not helpful against the highly contagious coronavirus that travels there. South Africa abruptly suspended plans to use the AstraZeneca vaccine and instead replaced the Johnson & Johnson and Pfizer / BioNTech vaccines.
Now scientists are waiting for the results of a great trials of the AstraZeneca vaccine made in the US and other countries that will be the company’s cornerstone for the vaccine to be approved by the FDA. But some experts are wondering if the addition of AstraZeneca to the US vaccine could cause some problems, and anti-vaxxers can take advantage of advertising Round to reduce the amount of vaccine.
“Does it have a full section? Can they be fully trusted? Or is it just another topic? ”Said Moore.
Children’s Health Defense, agency that has done so to deceive false and Conspiracy theories about vaccinations for years, they are already he lights up the news that several European countries are abandoning the vaccine.
Where the vaccine is most likely to change is in developing countries, especially in Africa, where the vaccine is available lagging far behind. Biden has difficulty delivering AstraZeneca vaccine to developing countries, The New York Times reports on March 11. Currently, COVAX – a joint venture with the WHO, Coalition for Epidemic Preparedness Innovations, and Gavi, the Vaccine Alliance, to provide affordable vaccines to developing countries – and relying on the use of the AstraZeneca vaccine giving hundreds of millions of dollars to developing countries.
“Security is our main concern: We know that government officials and WHO are monitoring the situation and that the COVAX Facility will follow its instructions and advice,” a Gavi spokesman said in response to questions from BuzzFeed News. “There is currently no link between the vaccine and other human activities, and the vaccine is still an important and effective tool in the fight against the epidemic.”